Tamer Coşkun

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents”.

Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents

Diabetes Obesity and Metabolism(2022)10.1111/dom.14843

N/A

0.590DataRank · unranked

50 citations

Meghan P. Antonellis, Wolfgang Trumbauer, Jennifer A. Martin, Tamer Coşkun, Ricardo J. Samms +2 more

Characterization of LY3324954 a long-acting glucagon-receptor agonist

Molecular Metabolism(2024)10.1016/j.molmet.2024.102073

N/A

0DataRank · unranked

10 citations

Tamer Coşkun, Teayoun Kim, Libbey S. O′Farrell, Jennifer A. Martin, Shelly Nason +8 more

Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction

Diabetes Obesity and Metabolism(2025)10.1111/dom.70063

N/A

0DataRank · unranked

7 citations

Alastair W. Knights, Éric Ravussin, Guillermo Sánchez‐Delgado, Hiroshi Nishiyama, Hui‐Rong Qian +6 more